Orin S. Levine
Johns Hopkins University
142 Papers
1.1K Citations
Orin S. Levine is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Pneumonia & Medicine. The author has an hindex of 50, co-authored 140 publications. Previous affiliations of Orin S. Levine include Bill & Melinda Gates Foundation & National Institutes of Health.
Chat about Author
Papers
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Katherine L. O'Brien,Lara J. Wolfson,James P. Watt,Emily Henkle,Maria Deloria-Knoll,Natalie McCall,Ellen Lee,Kim Mulholland,Orin S. Levine,Thomas Cherian +9 more
TL;DR: The burden of pneumococcal pneumonia is measured by applying the proportion of pneumonia cases caused by S pneumoniae derived from efficacy estimates from vaccine trials to WHO country-specific estimates of all-cause pneumonia cases and deaths, using disease incidence and case-fatality data from a systematic literature review.
2.4K
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
Felicity T. Cutts,Syed M. A. Zaman,Godwin Enwere,Shabbar Jaffar,Orin S. Levine,Orin S. Levine,J. B. Okoko,Claire Oluwalana,Adeola Vaughan,Steven Obaro,Amanda Leach,Keith P. W. J. McAdam,Ekow Biney,Mark Saaka,U. Onwuchekwa,Fred G. Yallop,Nathaniel F. Pierce,Brian Greenwood,Richard A. Adegbola +18 more
TL;DR: Pneumococcal conjugate vaccine has high efficacy against radiological pneumonia and invasive pneumococcal disease, and can substantially reduce admissions and improve child survival in this rural African setting.
988
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
Katherine L. O'Brien,Henry C. Baggett,W. Abdullah Brooks,Daniel R. Feikin,Laura L. Hammitt,Melissa M. Higdon,Stephen R. C. Howie,Maria Deloria Knoll,Karen L. Kotloff,Orin S. Levine,Shabir A. Madhi,David R. Murdoch,Christine Prosperi,J. Anthony G. Scott,Qiyuan Shi,Donald M. Thea,Zhenke Wu,Scott L. Zeger,Peter V. Adrian,Pasakorn Akarasewi,Trevor P. Anderson,Martin Antonio,Juliet O. Awori,Vicky L. Baillie,Charatdao Bunthi,James Chipeta,Mohammod Jobayer Chisti,Jane Crawley,Andrea DeLuca,Amanda J. Driscoll,Bernard E. Ebruke,Hubert P. Endtz,Nicholas Fancourt,Wei Fu,Doli Goswami,Michelle J. Groome,Meredith Haddix,Lokman Hossain,Yasmin Jahan,E Wangeci Kagucia,Alice Kamau,Ruth A. Karron,Sidi Kazungu,Nana Kourouma,Locadiah Kuwanda,Geoffrey Kwenda,Mengying Li,Eunice M. Machuka,Grant A. Mackenzie,Nasreen Mahomed,Susan A. Maloney,Jessica McLellan,Joanne L. Mitchell,David P. Moore,Susan C. Morpeth,Azwifarwi Mudau,Lawrence Mwananyanda,James Mwansa,Micah Silaba Ominde,Uma Onwuchekwa,Daniel E. Park,Julia Rhodes,Pongpun Sawatwong,Phil Seidenberg,Arifin Shamsul,Eric A. F. Simões,Seydou Sissoko,Somwe Wa Somwe,Samba O. Sow,Mamadou Sylla,Boubou Tamboura,Milagritos D. Tapia,Somsak Thamthitiwat,Aliou Toure,Nora L. Watson,Khalequ Zaman,Syed M. A. Zaman +76 more
TL;DR: Estimating causes of pneumonia in young African and Asian children, using novel analytical methods applied to clinical and microbiological findings, estimated that viruses accounted for 61·4% (95% credible interval [CrI] 57·3–65·6) of causes, whereas bacteria accounted for 27·3% (23·3-31·6).
758
Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.
Hope L. Johnson,Maria Deloria-Knoll,Orin S. Levine,Sonia K. Stoszek,Laura Freimanis Hance,Richard Reithinger,Larry R. Muenz,Katherine L. O'Brien +7 more
TL;DR: The global and regional burden of serotype-specific pneumococcal disease in children under the age of five and the role of vaccine-preventable disease in this burden is calculated.
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.
James P. Watt,Lara J. Wolfson,Katherine L. O'Brien,Emily Henkle,Maria Deloria-Knoll,Natalie McCall,Ellen Lee,Orin S. Levine,Rana A. Hajjeh,Kim Mulholland,Thomas Cherian +10 more
TL;DR: Global burden of Hib disease is substantial and almost entirely vaccine preventable, and expanded use of Hib vaccine could reduce childhood pneumonia and meningitis, and decrease child mortality.
501